Australia markets open in 2 hours 32 minutes

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.22+0.34 (+3.13%)
At close: 04:00PM EDT
11.22 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.46B
Enterprise value 3.62B
Trailing P/E N/A
Forward P/E 10.27
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.45
Price/book (mrq)0.98
Enterprise value/revenue 1.11
Enterprise value/EBITDA 16.61

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 37.30%
S&P500 52-week change 323.01%
52-week high 311.90
52-week low 36.37
50-day moving average 310.52
200-day moving average 39.47

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.42M
Shares outstanding 5134.47M
Implied shares outstanding 6134.47M
Float 873.76M
% held by insiders 111.87%
% held by institutions 189.16%
Shares short (15 Aug 2024) 47.53M
Short ratio (15 Aug 2024) 47.02
Short % of float (15 Aug 2024) 47.33%
Short % of shares outstanding (15 Aug 2024) 45.60%
Shares short (prior month 15 July 2024) 48.92M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -21.20%
Operating margin (ttm)8.41%

Management effectiveness

Return on assets (ttm)3.71%
Return on equity (ttm)-37.34%

Income statement

Revenue (ttm)3.26B
Revenue per share (ttm)24.43
Quarterly revenue growth (yoy)1.60%
Gross profit (ttm)N/A
EBITDA 662.08M
Net income avi to common (ttm)-690.24M
Diluted EPS (ttm)-5.22
Quarterly earnings growth (yoy)39.00%

Balance sheet

Total cash (mrq)74.72M
Total cash per share (mrq)0.57
Total debt (mrq)2.23B
Total debt/equity (mrq)149.33%
Current ratio (mrq)1.15
Book value per share (mrq)11.48

Cash flow statement

Operating cash flow (ttm)501.12M
Levered free cash flow (ttm)196.32M